調查批次 : RH2020-02 | 檢體寄出日期:2020 年 06 月 29 日 | 報告回收截止日期:2020 月 07 月 06 日 |
寄出份數 : 20 份 | 回收份數(比率) : 20 (100%) |
1.本次各單位 G6PD 及血色素 (Hb) 定量檢驗結果一覽表 | 4.至本次歷年品管檢體「調查批次」與「實驗室間 C.V.」分佈圖 |
2.本次 G6PD 定量檢驗結果分佈圖 | 5.至本次歷年品管檢體「G6PD 活性值」與「實驗室間 C.V.」分佈圖 |
3.本次血色素 (Hb) 定量檢驗結果分佈圖 | 6.至本次各單位 z score, D% 及 SDI 分佈圖列表 |
各單位G6PD及血色素(Hb)定量檢驗院際品管調查結果一覽表
確診醫院 代碼 |
檢驗單位 代碼 |
檢體寄 送時效 (天) |
回報時效 (天) |
Sample 1 (U/gHb) |
Sample 2 (U/gHb) |
Sample 3 (U/gHb) |
Hb 1 (g/dL) |
Hb 2 (g/dL) |
Hb 3 (g/dL) |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A0511 | CL002* | 0 | 3 | 5.1 | 7.0 | 13.2 | 2.3 | 2.2 | 2.1 | |||||||
RH01 | RH01* | 0 | 1 | 5.9 | 8.9 | 14.7 | 2.2 | 2.0 | 2.0 | |||||||
RH02 | RH02 | 0 | 7 | 5.4 | 7.9 | 14.5 | 2.1 | 2.0 | 2.0 | |||||||
RH03 | CL002* | 0 | 3 | 5.1 | 7.0 | 13.2 | 2.3 | 2.2 | 2.1 | |||||||
RH04 | RH04 | 0 | 7 | 5.0 | 8.9 | 14.9 | 2.2 | 2.0 | 2.0 | |||||||
RH05 | RH01* | 0 | 1 | 5.9 | 8.9 | 14.7 | 2.2 | 2.0 | 2.0 | |||||||
RH06 | RH06 | 1 | 4 | 5.5 | 8.5 | 14.0 | 2.2 | 2.1 | 2.1 | |||||||
RH07 | RH07* | 1 | 3 | 5.9 | 7.5 | 14.8 | 1.8 | 1.9 | 1.8 | |||||||
RH08 | RH08 | 1 | 5 | 5.7 | 8.2 | 14.4 | 2.0 | 2.0 | 2.0 | |||||||
RH09 | RH09 | 1 | 7 | 5.8 | 8.5 | 14.1 | 1.9 | 1.9 | 1.7 | |||||||
RH10 | RH10 | 1 | 3 | 5.4 | 6.8 | 14.1 | 2.0 | 1.9 | 1.9 | |||||||
RH11 | CL002* | 0 | 3 | 5.1 | 7.0 | 13.2 | 2.3 | 2.2 | 2.1 | |||||||
RH12 | RH12 | 1 | 7 | 5.8 | 8.6 | 15.8 | 2.1 | 2.0 | 2.0 | |||||||
RH13 | RH13 | 1 | 4 | 5.1 | 7.8 | 14.0 | 2.2 | 2.1 | 2.0 | |||||||
RH14 | RH14 | 1 | 7 | 5.4 | 8.7 | 14.2 | 2.3 | 2.1 | 2.1 | |||||||
RH16 | CL001 | 0 | 3 | 5.8 | 7.7 | 14.8 | 2.2 | 2.0 | 2.0 | |||||||
RH17 | CL002* | 0 | 3 | 5.1 | 7.0 | 13.2 | 2.3 | 2.2 | 2.1 | |||||||
RH18 | A0203* | 0 | 7 | 5.4 | 7.6 | 14.0 | 2.2 | 2.1 | 2.0 | |||||||
RH19 | RH19 | 1 | 4 | 5.2 | 7.5 | 13.7 | 2.2 | 2.1 | 2.0 | |||||||
A0189 | RH07* | 1 | 3 | 5.9 | 7.5 | 14.8 | 1.8 | 1.9 | 1.8 | |||||||
G026 | G026 | 1 | 4 | 5.3 | 8.0 | 14.6 | 2.2 | 2.1 | 2.1 | |||||||
G031 | CL002* | 0 | 3 | 5.1 | 7.0 | 13.2 | 2.3 | 2.2 | 2.1 | |||||||
CL004 | CL004 | 1 | 7 | 5.4 | 8.4 | 14.9 | 2.2 | 2.0 | 2.0 | |||||||
CL016 | CL002* | 0 | 3 | 5.1 | 7.0 | 13.2 | 2.3 | 2.2 | 2.1 | |||||||
B005 | CL002* | 0 | 3 | 5.1 | 7.0 | 13.2 | 2.3 | 2.2 | 2.1 | |||||||
CL014 | CL014 | 1 | 5 | 5.4 | 7.7 | 11.8 | 2.2 | 2.0 | 2.0 | |||||||
CL015B | CL015B | 1 | 3 | 5.4 | 8.5 | 14.0 | 2.2 | 2.1 | 2.0 | |||||||
CL017 | CL017 | 0 | 5 | 5.4 | 7.8 | 13.9 | 2.1 | 2.0 | 1.9 | |||||||
Total participating laboratories = 20 | ||||||||||||||||
Median | 1 | 4.5 | 5.4 | 8.0 | 14.2 | 2.2 | 2.0 | 2.0 | ||||||||
Note: * indicates this Lab Unit did analyzing for multiple referral hospitals and we only count once |
若有任何疑問,歡迎來電(函)聯繫或指教
地 址:10699
臺北信維郵局第 624 信箱 電 話:(02)2703-6080
e-mail:
傳 真: (02)2703-6070
財團法人預防醫學基金會
updated : 06 Jul, 2020